What is the key sign that a patient is not tolerating a modality well?

Prepare for the Modalities and Rehabilitation Exam. Use flashcards, multiple choice questions with hints, and explanations to ensure success. Get exam-ready now!

Multiple Choice

What is the key sign that a patient is not tolerating a modality well?

Explanation:
When evaluating tolerance to a modality, the clearest signal is the appearance of adverse reactions that go beyond what is expected. If a patient reports or shows increased pain, burning, numbness, skin irritation, or redness that is more than what the treatment typically causes, that indicates overstimulation or tissue irritation and means the modality should be stopped or adjusted immediately. Other responses don’t reliably show poor tolerance: rapid improvement in function might be encouraging but doesn’t tell you about how the tissue or nerves are handling the stimulus; no sensation change means the stimulus isn’t having a noticeable effect rather than indicating whether it’s well tolerated; and drowsiness during treatment could be a side effect of certain modalities but isn’t a universal sign of not tolerating the therapy. The key is monitoring for those adverse signs and tailoring the modality to keep the patient safe and comfortable.

When evaluating tolerance to a modality, the clearest signal is the appearance of adverse reactions that go beyond what is expected. If a patient reports or shows increased pain, burning, numbness, skin irritation, or redness that is more than what the treatment typically causes, that indicates overstimulation or tissue irritation and means the modality should be stopped or adjusted immediately. Other responses don’t reliably show poor tolerance: rapid improvement in function might be encouraging but doesn’t tell you about how the tissue or nerves are handling the stimulus; no sensation change means the stimulus isn’t having a noticeable effect rather than indicating whether it’s well tolerated; and drowsiness during treatment could be a side effect of certain modalities but isn’t a universal sign of not tolerating the therapy. The key is monitoring for those adverse signs and tailoring the modality to keep the patient safe and comfortable.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy